NuvaRing Birth Control

NuvaRing is a form of birth control that serves as an alternative to oral medication and the birth control patch. Approved by the Food and Drug Administration (FDA) in 2001, NuvaRing is a vaginal ring that releases progesterone and estrogen in a three-week cycle before it is removed for the fourth week.

NuvaRing was originally manufactured by Organon USA, a company purchased by Schering Plough in November 2007. This consolidation makes Schering Plough liable for any damages caused by Organon USA's defective drugs.

NuvaRing Side Effects: Blood Clots and Stroke

Several lawsuits have been filed against Schering Plough due to the potentially life-threatening side effects of NuvaRing. One report claimed a New Jersey woman died after developing a NuvaRing-induced blood clot.

Other reports claim that NuvaRing side effects include heart attack and breast cancer.

Recent research has found links between hormonal contraceptives and an increased risk for blood clotting and stroke, particularly the newest generation of hormonal contraceptives. On behalf of 100,000 consumers, the FDA is petitioning to recall all oral contraceptives that contain the deogestrel molecule, an element believed to cause blood clots.

Filing a NuvaRing Lawsuit

If you or someone you know has suffered an injury or died due to NuvaRing side effects, you may be entitled to compensation. The defective drug team of Aylstock, Witkin, Kreis and Overholtz fight diligently for their clients to receive the compensatory damages victims need to offset medical bills, lost income, and pain and suffering. To learn more about your rights as a NuvaRing victim, contact AWKO at (888) 255-2956.